In the International Financial Law Review’s latest publication, A Deep Dive Into Capital Raising Alternatives, Mayer Brown provides context on the changes in market structure and market dynamics that led to the enactment of the JOBS Act. Specifically, the trend for many private companies to remain private longer, defer or dispense with traditional

Private investment in public equity (“PIPE”) transactions completed in 2020* have raised over $53.0 billion, in aggregate, in 1055 transactions.  This is the largest sum of capital raised in PIPE transactions since 2008.  While industrials companies (chemicals, metals, mining and paper-focused companies) lead the market by number of PIPEs completed, the 323 deals in this

The National Center of the Middle Market (NCMM) conducted a survey from March 12-23, 2020 of 400 strategic decision makers from life sciences companies in the United States and Canada. The report noted middle market life sciences companies, which include companies with annual revenues between $10 million and $1 billion, have experienced robust growth. Between

Funding in the fintech sector increased 17% quarter-over-quarter, after two quarters of declines, to $9.3 billion according to CB Insights’ recent State of Fintech report. Despite the funding increase, the number of deals continued to decline globally, continuing the decline since the fourth quarter of 2019. In the second quarter of 2020, 397 global venture-backed

Special purpose acquisition companies (“SPACs”) are public shell companies that use their initial public offering (“IPO”) proceeds in order to acquire private companies within a specific timeframe.   Although SPACs have existed for decades, merging into a SPAC has recently become an attractive alternative for private companies in lieu of undertaking traditional IPOs.  Today, SPACs have

PIPE transactions continue to be a popular capital raising approach for companies.  Through July 31, 2020, companies have raised over $47.2 billion in 779 PIPE transactions.  Healthcare and life sciences companies raised almost $11 billion in PIPE transactions.  Technology and industrials companies also raised significant amounts of capital, totaling $10.1 billion and $9.2 billion, respectively.

The private investment in public equity (PIPE) transaction has proven to be a popular financing tool in volatile markets. For the first five months of 2020, $29.3 billion has been raised through PIPE transactions, primarily in the healthcare and technology sectors.

Data source: PrivateRaise

Comparing timeframes (January 1 through June 9) year-over-year since 2015, there

During the first quarter of 2020, venture funding levels in the global healthcare and life sciences sector has increased 4% by dollars raised, quarter-over-quarter, despite the turbulent COVID-19 environment. According to a recent CB Insights report, healthcare companies raised $14.6 billion this past quarter in 1,156 deals. Deal volume decreased 6% quarter-over-quarter. The inverse